SCHEMBL9738653

SCHEMBL9738653

CC(C)n1nc(C(=O)NC2CCCC2)nc1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1

nearest known ligand 0.35

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
TRPV1 Q8NER1 1/20 0.35
GAA P10253 1/20 0.35
USP1 O94782 1/20 0.35
HTR4 Q13639 1/20 0.35
TACR2 P21452 1/20 0.34
TACR3 P29371 1/20 0.34
OPRM1 P35372 1/20 0.34
ALDH1A1 P00352 2/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
LMNA P02545 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
SPR P35270 1/20 0.34
PDE6D O43924 1/20 0.34
PPARG P37231 2/20 0.33
PTGS2 P35354 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9738503 0.99 TRPV1 (0.36) TRPV1GAAUSP1HTR4TACR2
SCHEMBL9737978 0.88 AGTR1 (0.34) ALDH1A1PTGS2
SCHEMBL9738134 0.88 AGTR1 (0.35) ALDH1A1
SCHEMBL9740009 0.86 AGTR1 (0.39)
SCHEMBL9740299 0.86 RIPK1 (0.42) GAAALDH1A1SMN1; SMN2MEN1KMT2A
SCHEMBL9738648 0.86 RIPK1 (0.42) GAAALDH1A1SMN1; SMN2MEN1KMT2A
SCHEMBL9738099 0.86 RIPK1 (0.35) GAAALDH1A1SMN1; SMN2MEN1KMT2A
SCHEMBL9738516 0.86 AGTR1 (0.36)
SCHEMBL9738129 0.86 AGTR1 (0.35)
SCHEMBL9739505 0.86 RIPK1 (0.37) GAAALDH1A1SMN1; SMN2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1992005161-A1 1,3,5-TRISUBSTITUTED-1,2,4-TRIAZOLE COMPOUNDS FOR TREATMENT OF CIRCULATORY DISORDERS G.D. SEARLE & CO. (US) 1992-04-02 WO claimed
WO-1992005161-A1 1,3,5-TRISUBSTITUTED-1,2,4-TRIAZOLE COMPOUNDS FOR TREATMENT OF CIRCULATORY DISORDERS G.D. SEARLE & CO. (US) 1992-04-02 WO disclosed